% | $
Quotes you view appear here for quick access.

Boston Scientific Corporation Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • terribc terribc Apr 15, 1999 5:59 PM Flag


    No hard information on the fate of Cordis with a
    JNJ/BSX merger. Potential with BSX pipeline to let them
    operate in the manner SCIMED has been managed since their
    buyout. BSX array of products may make them attractive
    enough with the duplication to add the the JNJ stable.
    Also, JNJ may weigh the future prospects for Cordis
    worth less than premium for BSX buyout. Don't have more
    than rumors. However, news in past and on board has
    been flat.

14.81-0.05(-0.30%)4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.